CYTK – cytokinetics, incorporated (US:NASDAQ)
Stock Stats
News
Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
Why Cytokinetics Stock Was a Nearly 5% Winner Today [Yahoo! Finance]
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Form 4 CYTOKINETICS INC For: Jan 02 Filed by: HENDERSON JOHN T
Form 4 CYTOKINETICS INC For: Jan 02 Filed by: Harrington Robert Arthur
Form 4 CYTOKINETICS INC For: Jan 02 Filed by: Kaye Edward M. MD
Form 4 CYTOKINETICS INC For: Jan 02 Filed by: Wysenski Nancy
Form 4 CYTOKINETICS INC For: Jan 02 Filed by: WIERENGA WENDALL
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.